Patents by Inventor Jeney RAMÍREZ SÁNCHEZ

Jeney RAMÍREZ SÁNCHEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A FLAVANOID EXTRACT OBTAINED FROM THE SPECIES TALIPARITI ELATUM SW, FORMULATIONS COMPRISING SAME AND TREATMENT METHOD
    Publication number: 20240123008
    Abstract: This invention is related to the field of healthcare and especially to the treatment of memory disorders. The invention consists in the preparation of oral pharmaceutical formulations from an extract of flavonoids obtained from the species Talipairti elatum Sw., which acts improving the different types of memory, both in the short and long-term associated with different pathologies and with population aging in humans.
    Type: Application
    Filed: November 13, 2020
    Publication date: April 18, 2024
    Applicant: CENTRO DE INVESTIGACION Y DESARROLLO DE MEDICAMENTOS (CIDEM)
    Inventors: Maylin WONG GUERRA, Jeney RAMIREZ SANCHEZ, Luis Arturo FONSECA FONSECA, Yanier NÚÑEZ FIGUEREDO, Alejandro Saul PADRON YAQUIS, Loraine Licet INFANTE BLANCO, Jacqueline Aylema ROMERO DIAZ, Maydel BARRIOS SARMIENTO, Yanay MONTANO PEGUERO
  • Benzodiazepine product with activity on the central nervous and vascular systems
    Patent number: 11098039
    Abstract: Formula III compound, its products and pharmaceutical compositions containing them for the treatment of central nervous and vascular system diseases, particularly neurodegenerative disorders with cognitive deterioration, diseases associated with oxidative stress, diseases taking in mitochondrial dysfunction, Parkinson's disease and neuropathic pain, as well as the pathological processes associated with aging.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: August 24, 2021
    Assignees: UNIVERSIDAD DE LA HABANA, CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM
    Inventors: Yanier Núñez Figueredo, Maylin Wong Guerra, Luis Arturo Fonseca Fonseca, Bárbara Beatriz Garrido Suárez, Jeney Ramírez Sánchez, Gilberto Lázaro Pardo Andreu, Yamila Verdecia Reyes, Estael Ochoa Rodríguez, Pedro Gilberto Bárzaga Fernández, Nicté González Alfonso, René Delgado Hernández, Alejandro Saúl Padrón Yaquis
  • Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems
    Patent number: 10722491
    Abstract: The present invention relates to Chemistry, Pharmaceutical and in particular to the preparation of formulations from derivatives of phenolic or polyphenolic compounds and from derivatives of phenolic or polyphenolic compounds combined with tricyclic systems of the benzodiazepine type fused to derivatives of 1,4-dihydropyridines with action on the Central Nervous and Vascular Systems. These pharmaceutical compositions exhibit GABAergic, antiglutamatergic, calcium channel modulating, mitoprotective, anti-oxidant, anti-inflammatory, and antiapoptotic action, usable in the treatment of cardiovascular, cerebrovascular, neurodegenerative, neuropsychiatric and neurological diseases.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: July 28, 2020
    Assignees: UNIVERSIDAD DE LA HABANA, CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM
    Inventors: Estael Ochoa Rodríguez, Yamila Verdecia Reyes, Yanier Núñez Figueredo, Jeney Ramírez Sánchez, Maylin Wong Guerra, Luis Arturo Fonseca Fonseca, Gilberto Lázaro Pardo Andreu, Claudia Amanda Canaán-Haden Navarro, Abel Mondelo Rodríguez, Pedro Gilberto Bárzaga Fernández, Nicté González Alfonso, René Delgado Hernández, Alejandro Saúl Padrón Yaquis
  • BENZODIAZEPINE PRODUCT WITH ACTIVITY ON THE CENTRAL NERVOUS AND VASCULAR SYSTEMS
    Publication number: 20190270738
    Abstract: Formula III compound, its products and pharmaceutical compositions containing them for the treatment of central nervous and vascular system diseases, particularly neurodegenerative disorders with cognitive deterioration, diseases associated with oxidative stress, diseases taking in mitochondrial dysfunction, Parkinson's disease and neuropathic pain, as well as the pathological processes associated with aging.
    Type: Application
    Filed: May 3, 2017
    Publication date: September 5, 2019
    Inventors: Yanier NÚÑEZ FIGUEREDO, Maylin WONG GUERRA, Luis Arturo FONSECA FONSECA, Bárbara Beatriz GARRIDO SUÁREZ, Jeney RAMÍREZ SÁNCHEZ, Gilberto Lázaro PARDO ANDREU, Yamila VERDECIA REYES, Estael OCHOA RODRÍGUEZ, Pedro Gilberto BÁRZAGA FERNÁNDEZ, Nicté GONZÁLEZ ALFONSO, René DELGADO HERNÁNDEZ, Saúl Alejandro PADRÓN YAQUIS
  • PHENOL COMPOUND AND COMBINATION OF SAME WITH A BENZODIAZEPINE FUSED TO 1,4-DIHYDROPYRIDINE FOR TREATING DISEASES OF THE CENTRAL NERVOUS AND VASCULAR SYSTEMS
    Publication number: 20190133996
    Abstract: The present invention relates to Chemistry, Pharmaceutical and in particular to the preparation of formulations from derivatives of phenolic or polyphenolic compounds and from derivatives of phenolic or polyphenolic compounds combined with tricyclic systems of the benzodiazepine type fused to derivatives of 1,4-dihydropyridines with action on the Central Nervous and Vascular Systems. These pharmaceutical compositions exhibit GABAergic, antiglutamatergic, calcium channel modulating, mitoprotective, anti-oxidant, anti-inflammatory, and antiapoptotic action, usable in the treatment of cardiovascular, cerebrovascular, neurodegenerative, neuropsychiatric and neurological diseases.
    Type: Application
    Filed: May 3, 2017
    Publication date: May 9, 2019
    Inventors: Estael OCHOA RODRÍGUEZ, Yamila VERDECIA REYES, Yanier NÚÑEZ FIGUEREDO, Jeney RAMÍREZ SÁNCHEZ, Maylin WONG GUERRA, Luis Arturo FONSECA FONSECA, Gilberto Lázaro PARDO ANDREU, Claudia Amanda CANAÁN-HADEN NAVARRO, Abel MONDELO RODRÍGUEZ, Pedro Gilberto BÁRZAGA FERNÁNDEZ, Nicté GONZÁLEZ ALFONSO, René DELGADO HERNÁNDEZ, Alejandro Saúl PADRÓN YAQUIS